Targeting sarcoma tumor-initiating cells through differentiation therapy
Human leukocyte antigen class I (HLA-I) down-regulation has been reported in many human cancers to be associated with poor clinical outcome. However, its connection to tumor-initiating cells (TICs) remains unknown. In this study, we report that HLA-I is down-regulated in a subpopulation of cells tha...
Main Authors: | Dan Han, Veronica Rodriguez-Bravo, Elizabeth Charytonowicz, Elizabeth Demicco, Josep Domingo-Domenech, Robert G. Maki, Carlos Cordon-Cardo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-05-01
|
Series: | Stem Cell Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506117300703 |
Similar Items
-
Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood
by: Pei-Wen Fan, et al.
Published: (2018-01-01) -
Human leukocyte antigen-A, B, and DRB1 diversity in renal transplant patients and donors: A single-center retrospective observational study
by: Vikash Chandra Mishra, et al.
Published: (2022-01-01) -
Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations
by: Malte Simon, et al.
Published: (2021-05-01) -
Association of Class I Human Leukocyte Antigen in Iraqi Patients with Hodgkin’s Lymphoma
by: Ruqaya M. Al-Barzinji
Published: (2013-09-01) -
Diversity of the Swine Leukocyte Antigen Class I and II in Commercial Pig Populations
by: Navapon Techakriengkrai, et al.
Published: (2021-04-01)